Post-thrombectomy management of the ELVO patient: Guidelines from the Society of NeuroInterventional Surgery
暂无分享,去创建一个
J. Mocco | P. Meyers | S. Hetts | K. Bulsara | B. Baxter | S. Ansari | M. Jayaraman | R. McTaggart | R. Starke | J. Fraser | W. Mack | A. Arthur | T. Leslie-Mazwi | C. Prestigiacomo | R. Klucznik | C. Gandhi | D. Heck | P. Sunenshine | D. Frei | G. Pride | Michael Chen | M. Hussain | J. D. Delgado Almandoz | P. Rasmussen | T. Abruzzo | J. Yi | A. Patsalides | B. Albani | S. Lee | P. M. Meyers | M. Hussain | R. M. Starke | C. Gandhi | S. Hetts | M. V. Jayaraman | W. Mack | J. F. Fraser | William J Mack | Justin F. Fraser | Chirag D. Gandhi | R. Starke
[1] J. Peters,et al. National Institute of Neurological Disorders and Stroke , 2014, Definitions.
[2] R. Sacco,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. , 2019, Stroke.
[3] Hester F. Lingsma,et al. Letter by Mulder et al Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". , 2019, Stroke.
[4] R. Conwit,et al. Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy – Magnesium) , 2017, Stroke.
[5] L. Parker,et al. Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] J. Mocco,et al. Prehospital care delivery and triage of stroke with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of Neurointerventional Surgery , 2016, Journal of NeuroInterventional Surgery.
[7] J. Fraser,et al. Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Training Guidelines for Endovascular Ischemic Stroke Intervention: An International multi-society consensus document , 2016, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.
[9] London,et al. Training Guidelines for Endovascular Ischemic Stroke Intervention: An International multi-society consensus document , 2016, Journal of NeuroInterventional Surgery.
[10] B. Rochwerg,et al. Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. , 2015, JAMA.
[11] Daniel E. Ray,et al. Integrating Palliative Care Into the Care of Neurocritically Ill Patients: A Report From the Improving Palliative Care in the ICU Project Advisory Board and the Center to Advance Palliative Care* , 2015, Critical care medicine.
[12] M. Chen,et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery , 2015, Journal of NeuroInterventional Surgery.
[13] H. Diener,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.
[14] A. Demchuk,et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.
[15] Coleman O. Martin,et al. Groin complications in endovascular mechanical thrombectomy for acute ischemic stroke: a 10-year single center experience , 2015, Journal of NeuroInterventional Surgery.
[16] Chin-Hao Chang,et al. Access site complications following transfemoral coronary procedures: comparison between traditional compression and angioseal vascular closure devices for haemostasis , 2015, BMC Cardiovascular Disorders.
[17] N. Yamada,et al. Clinical management provided by board-certificated physiatrists in early rehabilitation is a significant determinant of functional improvement in acute stroke patients: a retrospective analysis of Japan rehabilitation database. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[18] M. Krause,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.
[19] Eric E. Smith,et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.
[20] Á. Chamorro,et al. Relevance of Blood–Brain Barrier Disruption After Endovascular Treatment of Ischemic Stroke: Dual-Energy Computed Tomographic Study , 2015, Stroke.
[21] J. Mocco,et al. Prospective series of two hours supine rest after 4fr sheath-based diagnostic cerebral angiography: Outcomes, productivity and cost , 2015, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.
[22] Hester F. Lingsma,et al. A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.
[23] C. Molina,et al. Early transfer of stroke patients to comprehensive stroke centers: David and Goliath. , 2014, Stroke.
[24] Rishi Gupta,et al. Disposition to home or acute rehabilitation is associated with a favorable clinical outcome in the SENTIS trial , 2014, Journal of NeuroInterventional Surgery.
[25] W. Hacke,et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. , 2014, The New England journal of medicine.
[26] A. Demchuk,et al. Hemicraniectomy and Durotomy Upon Deterioration From Infarction-Related Swelling Trial: Randomized Pilot Clinical Trial , 2014, Stroke.
[27] J. Chen,et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.
[28] G. Schulte-Altedorneburg,et al. Hyperattenuated Intracerebral Lesions after Mechanical Recanalization in Acute Stroke , 2014, American Journal of Neuroradiology.
[29] A. Kastrati,et al. Bleeding complications in patients undergoing percutaneous coronary interventions: current status and perspective. , 2014, Coronary artery disease.
[30] F. Sharp,et al. Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] R. Nogueira,et al. Discharge disposition to skilled nursing facility after endovascular reperfusion therapy predicts a poor prognosis , 2014, Journal of NeuroInterventional Surgery.
[32] Michael D Hill,et al. High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial , 2013, The Lancet Neurology.
[33] M. Woodward,et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.
[34] E. Jüttler,et al. Space-occupying cerebellar infarction: complications, treatment, and outcome. , 2013, Neurosurgical focus.
[35] B. Walters,et al. Infection risk in neurointervention and cerebral angiography. , 2013, Neurosurgery.
[36] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[37] J. Serfaty,et al. Blood–brain barrier disruption is associated with increased mortality after endovascular therapy , 2013, Neurology.
[38] K. Furie,et al. Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients , 2013, Neurocritical Care.
[39] R. Raman,et al. Comprehensive Stroke Centers and the ‘Weekend Effect’: The SPOTRIAS Experience , 2012, Cerebrovascular Diseases.
[40] Michael D Hill,et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial , 2012, The Lancet Neurology.
[41] J. Simard,et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas , 2012, Annals of neurology.
[42] R. Hernández-Clares,et al. Hemorrhage/Contrast Staining Areas after Mechanical Intra-Arterial Thrombectomy in Acute Ischemic Stroke: Imaging Findings and Clinical Significance , 2012, American Journal of Neuroradiology.
[43] Mario Zuccarello,et al. pCO2 and pH regulation of cerebral blood flow , 2012, Front. Physio..
[44] Yan Zhang,et al. Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarct: A Randomized Controlled Trial Enrolling Patients up to 80 Years Old , 2012, Neurocritical Care.
[45] K. Fargen,et al. Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal , 2012, Journal of NeuroInterventional Surgery.
[46] F. Rincon. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease , 2012 .
[47] Ming Liu,et al. Edaravone for acute ischaemic stroke. , 2011, The Cochrane database of systematic reviews.
[48] G. Rosenberg,et al. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.
[49] S. Kasner,et al. Comprehensive Stroke Centers Overcome the Weekend Versus Weekday Gap in Stroke Treatment and Mortality , 2011, Stroke.
[50] J. Switzer,et al. Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke , 2011, Stroke.
[51] M. Kaste,et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis , 2011, Neurology.
[52] H. Diener,et al. Partial Aortic Occlusion for Cerebral Perfusion Augmentation: Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke Trial , 2011, Stroke.
[53] J. Chalela,et al. Osmotherapy: Use Among Neurointensivists , 2011, Neurocritical care.
[54] H. Kamel,et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials* , 2011, Critical care medicine.
[55] T. Videen,et al. Cerebral Hemodynamic and Metabolic Effects of Equi-Osmolar Doses Mannitol and 23.4% Saline in Patients with Edema Following Large Ischemic Stroke , 2011, Neurocritical care.
[56] J. Marc Simard,et al. Novel Treatment Targets for Cerebral Edema , 2011, Neurotherapeutics.
[57] C. Gerloff,et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study , 2010, Annals of neurology.
[58] Christianne Leidecker,et al. Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining. , 2010, Radiology.
[59] J. Switzer,et al. Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study , 2010, Stroke.
[60] S. Payne,et al. The palliative care needs of acute stroke patients: a prospective study of hospital admissions. , 2010, Age and ageing.
[61] M. Jayaraman,et al. StarClose Vascular Closure Device: Safety and Efficacy of Deployment and Reaccess in a Neurointerventional Radiology Service , 2010, American Journal of Neuroradiology.
[62] W. Aronow,et al. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. , 2010, The Journal of invasive cardiology.
[63] J. Álvarez-Sabín,et al. Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful? , 2010, Journal of neurosurgery.
[64] S. Payne,et al. End-of-life issues in acute stroke care: a qualitative study of the experiences and preferences of patients and families , 2010, Palliative medicine.
[65] C. Mazzocato,et al. The last days of dying stroke patients referred to a palliative care consult team in an acute hospital , 2010, European journal of neurology.
[66] D. Marion,et al. Contemporary Management of Traumatic Intracranial Hypertension: Is There a Role for Therapeutic Hypothermia? , 2009, Neurocritical care.
[67] M. Franceschini,et al. The Role of the Physiatrist in Stroke Rehabilitation: A European Survey , 2009, American journal of physical medicine & rehabilitation.
[68] K. Polderman,et al. Mechanisms of action, physiological effects, and complications of hypothermia , 2009, Critical care medicine.
[69] A. Algra,et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial , 2009, The Lancet Neurology.
[70] Michael D Hill,et al. Impact of a Stroke Unit on Length of Hospital Stay and In-Hospital Case Fatality , 2009, Stroke.
[71] J. Grotta,et al. Can Comprehensive Stroke Centers Erase the ‘Weekend Effect’? , 2008, Cerebrovascular Diseases.
[72] D. Manawadu,et al. Hemicraniectomy for Massive Middle Cerebral Artery Infarction: A Review , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[73] R. Geocadin,et al. Reversal of transtentorial herniation with hypertonic saline , 2008, Neurology.
[74] A. Rabinstein. Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm , 2008 .
[75] B. Meyer,et al. Effect of Endovascular Hypothermia on Acute Ischemic Edema: Morphometric Analysis of the ICTuS Trial , 2008, Neurocritical care.
[76] S. Schwab,et al. Antiedema Therapy in Ischemic Stroke , 2007, Stroke.
[77] W. Hacke,et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): A Randomized, Controlled Trial , 2007, Stroke.
[78] I. Janszky,et al. Weekend versus weekday admission and stroke outcome in Sweden from 1968 to 2005. , 2007, Stroke.
[79] E. Vicaut,et al. Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial) , 2007, Stroke.
[80] U. Dirnagl,et al. Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke , 2007, Stroke.
[81] J. Saver. Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm , 2007, Stroke.
[82] W. Poon,et al. SYMPTOMATIC AUTOREGULATORY FAILURE IN ACUTE ISCHEMIC STROKE , 2007, Neurology.
[83] Gustavo Saposnik,et al. Weekends: A Dangerous Time for Having a Stroke? , 2007, Stroke.
[84] E. Vicaut,et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials , 2007, Lancet Neurology.
[85] T. Videen,et al. Symptomatic autoregulatory failure in acute ischemic stroke , 2007, Neurology.
[86] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.
[87] Peter Langhorne,et al. Organised inpatient (stroke unit) care for stroke. , 2007, The Cochrane database of systematic reviews.
[88] J. Hauw,et al. Predictors for malignant middle cerebral artery infarctions , 2006, Neurology.
[89] J. Ormiston,et al. Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation. , 2006, The American journal of cardiology.
[90] B. Norrving,et al. The Swedish Malignant Middle cerebral artery Infarction Study: long‐term results from a prospective study of hemicraniectomy combined with standardized neurointensive care , 2006, Acta neurologica Scandinavica.
[91] J. Kassubek,et al. Safety and Therapeutical Benefit of Hemicraniectomy Combined with Mild Hypothermia in Comparison with Hemicraniectomy Alone in Patients with Malignant Ischemic Stroke , 2006, Cerebrovascular Diseases.
[92] R. Geocadin,et al. Safety of induced hypertension therapy in patients with acute ischemic stroke , 2006, Neurocritical care.
[93] W. K. D. Paula. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. , 2005, Neurology.
[94] A. Thrift,et al. Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? , 2005, Cerebrovascular Diseases.
[95] R. Shaw,et al. Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[96] G. Ekuklu,et al. Factors affecting the outcome of decompressive craniectomy for large hemispheric infarctions: a prospective cohort study , 2005, Acta Neurochirurgica.
[97] M. Edwards,et al. Trial , 2004, The Lancet.
[98] Jan Sobesky,et al. Identifying Thresholds for Penumbra and Irreversible Tissue Damage , 2004, Stroke.
[99] K. Furie,et al. Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.
[100] S. Warach,et al. Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption , 2004, Stroke.
[101] P. Nightingale,et al. The effects of position on oxygen saturation in acute stroke: a systematic review , 2004, Clinical rehabilitation.
[102] D. Krieger,et al. Cooling for Acute Ischemic Brain Damage (COOL AID) , 2004, Neurology.
[103] M. Hartmann,et al. Does acute occlusion of the carotid T invariably have a poor outcome? , 2004, Neurology.
[104] D. Hasan,et al. Clinical Course and Surgical Management of Massive Cerebral Infarction , 2004, Neurosurgery.
[105] R. Baumgartner,et al. Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke , 2004, Neurology.
[106] C. Parvin,et al. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations , 2004, Critical care medicine.
[107] M. Müllner,et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.
[108] S. Mayer,et al. Optimizing blood pressure in neurological emergencies , 2004, Neurocritical care.
[109] Albert van der Zwan,et al. Anatomy and Functionality of Leptomeningeal Anastomoses: A Review , 2003, Stroke.
[110] J. Ulatowski,et al. A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.
[111] H. Dieterich,et al. Influence of a Long-Term, High-Dose Volume Therapy with 6% Hydroxyethyl Starch 130/0.4 or Crystalloid Solution on Hemodynamics, Rheology and Hemostasis in Patients with Acute Ischemic Stroke , 2003, Pathophysiology of Haemostasis and Thrombosis.
[112] C. Ayata,et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: A multicenter review , 2003, Critical care medicine.
[113] J. Serena,et al. Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke , 2003, Stroke.
[114] H. Dieterich,et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. , 2003, Pathophysiology of haemostasis and thrombosis.
[115] K. Asplund,et al. Haemodilution for acute ischaemic stroke. , 2002, The Cochrane database of systematic reviews.
[116] StefanSchwarz,et al. Effects of Induced Hypertension on Intracranial Pressure and Flow Velocities of the Middle Cerebral Arteries in Patients With Large Hemispheric Stroke , 2002 .
[117] P. Riggs,et al. Management of Infected Femoral Closure Devices , 2002, Cardiovascular surgery.
[118] Stefan Schwab,et al. Effects of Body Position on Intracranial Pressure and Cerebral Perfusion in Patients With Large Hemispheric Stroke , 2002, Stroke.
[119] G. Cherr,et al. Infection is an Unusual But Serious Complication of a Femoral Artery Catheterization Site Closure Device , 2001, Annals of vascular surgery.
[120] F. Buonanno,et al. A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.
[121] J. Koziol,et al. Suboptimum hemicraniectomy as a cause of additional cerebral lesions in patients with malignant infarction of the middle cerebral artery. , 2001, Journal of neurosurgery.
[122] S. Lewington,et al. Corticosteroids for acute ischaemic stroke. , 2002, The Cochrane database of systematic reviews.
[123] E. Wijdicks,et al. Neuroimaging in Deteriorating Patients With Cerebellar Infarcts and Mass Effect , 2000, Stroke.
[124] D. Baim,et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. , 2000, The American journal of cardiology.
[125] J. Schramm,et al. Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study , 1999, Journal of Neurology.
[126] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[127] W. Hacke,et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. , 1998, Stroke.
[128] S. Slørdahl,et al. Stroke unit treatment improves long-term quality of life: a randomized controlled trial. , 1998, Stroke.
[129] J. Bogousslavsky,et al. Large infarcts in the middle cerebral artery territory Etiology and outcome patterns , 1998, Neurology.
[130] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[131] O. Rønning,et al. Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial. , 1998, Stroke.
[132] W Hacke,et al. Barbiturate coma in severe hemispheric stroke , 1997, Neurology.
[133] T. N. t-P. S. S. Group,et al. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.
[134] W. Hacke,et al. 'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs , 1996 .
[135] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[136] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[137] J. Frank. Large hemispheric infarction, deterioration, and intracranial pressure , 1995, Neurology.
[138] W. Schaper,et al. Collateral Circulation , 1993, Springer US.
[139] R. Myers,et al. Hemorrhagic infarct conversion in experimental stroke. , 1992, Annals of emergency medicine.
[140] V. Marder,et al. Thrombolytic therapy: current status (2). , 1988, The New England journal of medicine.
[141] V. Marder,et al. Thrombolytic therapy: current status (1). , 1988, The New England journal of medicine.
[142] V. Hachinski,et al. Early Mortality Following Stroke: A Prospective Review , 1984, Stroke.
[143] B. Siesjö,et al. Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.
[144] T. Simon,et al. Thrombolytic therapy: Current status. , 1975, The New England journal of medicine.